Acrivon Therapeutics, Inc. (ACRV)

Profile

Full Name

Acrivon Therapeutics, Inc.

Ticker

NASDAQ: ACRV

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

November 15, 2022

Indexes

Not included

Website

http://acrivon.com

Employees

75

Key Details

Price

$1.32(-0.75%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$2.38(+13.14% YoY)

PE ratio

-

Next earnings date

Aug 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.32
    ACRV price is $1.32

    30-Day Relative Volume

    1.08
    ACRV 30-day relative volume is 1.08

    Price Performance

    Price Today change

    -0.75%
    ACRV price is down -0.75% today

    Price YTD change

    -78.07%
    ACRV price is down -78.07% since January 1st

    Price 1-year change

    -83.98%
    ACRV price is down -83.98% year-on-year

    Price 3-year change

    -
    ACRV price 3-year change is unknown

    Price Range

    Price All-time high

    $25.47
    ACRV price is currently -94.82% below its historical high of $25.47

    Price 3-year low

    $1.05
    ACRV price is currently +25.71% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $41.39M
    ACRV market capitalization is $41.39 million

    Market cap 3-year change

    -
    ACRV market capitalization 3-year change is unknown

    Market cap All-time high

    $508.55M
    ACRV market capitalization is currently -91.86% below its historical high of $508.55 million

    Market cap sector rank

    31.82%
    ACRV market capitalization is higher than 31.82% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1.26%
    ACRV shares outstanding is up +1.26% year-on-year

    Shares Outstanding 3-Year Change

    -
    ACRV shares outstanding 3-year change is unknown

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.75
    ACRV beta is 1.75

    200-day SMA

    $4.26
    ACRV price is currently -69.03% below its 200-day simple moving average

    50-day SMA

    $1.26
    ACRV price is currently +4.68% above its 50-day simple moving average

    RSI

    48.46
    ACRV 14-day relative strength index is 48.46

    Volume

    1.08
    ACRV 30-day relative volume is 1.08

    ATR

    $0.10
    ACRV average true range is $0.10

    10-day Historical Volatility

    56.69%
    ACRV 10-day historical volatility is 56.69%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    ACRV annual revenue value is unknown

    Revenue Analysts estimate

    $129.33K
    ACRV annual revenue is currently equal to the consensus analysts' forecast

    Revenue 1-year change

    -
    ACRV annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    ACRV annual revenue is unknown

    EPS

    EPS

    -$2.38
    ACRV annual earnings per share is -$2.38

    EPS Analysts estimate

    -$2.24
    ACRV annual earnings per share is currently +6.41% higher than the consensus analysts' forecast

    EPS 1-year change

    +13.14%
    ACRV annual earnings per share is up +13.14% year-on-year

    EPS Sector rank

    35.77%
    ACRV annual earnings per share is higher than 35.77% of companies in Healthcare sector

    Profit

    Gross profit

    -
    ACRV annual gross profit value is unknown

    Gross margin

    -
    ACRV annual gross profit margin value is unknown

    Operating profit

    -$89.20M
    ACRV annual operating income is -$89.20 million

    Operating margin

    -
    ACRV annual operating profit margin value is unknown

    Net income

    -$80.56M
    ACRV annual net profit is -$80.56 million

    Net margin

    -
    ACRV annual net profit margin value is unknown

    Expenses

    Total expenses

    $89.20M
    ACRV annual total expenses is $89.20 million

    Operating expenses

    $89.20M
    ACRV annual total operating expenses is $89.20 million

    Cost of goods sold

    -
    ACRV annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $25.21M
    ACRV annual SGA is $25.21 million

    Depreciation and amortization

    $1.01M
    ACRV annual depreciation & amortization is $1.01 million

    Interest expense

    -
    ACRV annual interest expense value is unknown

    Income tax

    -
    ACRV annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$89.20M
    ACRV annual earnings before interest & taxes is -$89.20 million

    EBITDA

    -$88.19M
    ACRV annual EBITDA is -$88.19 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $196.59M
    ACRV annual total assets is $196.59 million

    Non current assets

    $14.96M
    ACRV annual long term assets is $14.96 million

    Current assets

    $181.63M
    ACRV annual total current assets is $181.63 million

    Cash and cash equivalents

    $39.82M
    ACRV annual cash & cash equivalents is $39.82 million

    Accounts receivable

    -
    ACRV annual accounts receivable value is unknown

    Inventory

    -
    ACRV annual inventory value is unknown

    Liabilities

    Total liabilities

    $19.80M
    ACRV annual total liabilities is $19.80 million

    Long term liabilities

    $2.59M
    ACRV annual total long term liabilities is $2.59 million

    Current liabilities

    $17.21M
    ACRV annual total current liabilities is $17.21 million

    Accounts payable

    $758.00K
    ACRV annual accounts payable is $758.00 thousand

    Debt

    Total debt

    $3.65M
    ACRV annual total debt is $3.65 million

    Total debt 1-year change

    -21.51%
    ACRV annual total debt is down -21.51% year-on-year

    Long term debt

    $2.59M
    ACRV annual long term debt is $2.59 million

    Short term debt

    $1.06M
    ACRV annual short term debt is $1.06 million

    Equity & Capital

    Shareholders equity

    $176.79M
    ACRV annual stockholders equity is $176.79 million

    Book value

    $176.79M
    ACRV annual book value is $176.79 million

    Retained earnings

    -$196.98M
    ACRV annual retained earnings is -$196.98 million

    Working capital

    $164.41M
    ACRV annual working capital is $164.41 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$65.67M
    ACRV annual cash flow from operations is -$65.67 million

    Cash from operations 1-year change

    -54%
    ACRV annual cash flow from operations is down -54% year-on-year

    Cash from investing

    -$51.77M
    ACRV annual cash flow from investing activities is -$51.77 million

    Cash from investing 1-year change

    -202.08%
    ACRV annual cash flow from investing activities is down -202.08% year-on-year

    Cash from financing

    $121.03M
    ACRV annual cash flow from financing activities is $121.03 million

    Cash from financing 1-year change

    +7888.1%
    ACRV annual cash flow from financing activities is up +7888.1% year-on-year

    CAPEX

    CAPEX

    -
    ACRV annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    ACRV annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$68.44M
    ACRV annual free cash flow is -$68.44 million

    Free cash flow 1-year change

    -55.79%
    ACRV annual free cash flow is down -55.79% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    ACRV annual gross profit margin value is unknown

    Operating margin

    -
    ACRV annual operating profit margin value is unknown

    Net margin

    -
    ACRV annual net profit margin value is unknown

    ROA & ROE

    ROA

    -40.98%
    ACRV annual return on assets is -40.98%

    ROE

    -45.57%
    ACRV annual return on equity is -45.57%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ACRV price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ACRV price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.26
    ACRV price to book ratio is 0.26

    PB ratio Sector rank

    20.26%
    ACRV price to book ratio is higher than 20.26% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    ACRV price to sales ratio value is unknown

    PS ratio Sector rank

    -
    ACRV price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $5.75M
    ACRV enterprise value is $5.75 million

    Enterprise value Sector rank

    17.53%
    ACRV enterprise value is higher than 17.53% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.06
    ACRV EV/EBITDA is -0.06

    EV/EBITDA Sector rank

    65.37%
    ACRV EV/EBITDA is higher than 65.37% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    10.55
    ACRV annual current ratio is 10.55

    Quick ratio

    -
    ACRV annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.02
    ACRV annual debt to equity ratio is 0.02

    Interest coverage ratio

    -
    ACRV annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    ACRV piotroski f-score value is unknown

    Altman Z-Score

    -
    ACRV altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    May 16, 25 Jones Trading
    Hold
    May 15, 25 Oppenheimer
    Outperform
    Mar 28, 25 HC Wainwright & Co.
    Buy
    Mar 26, 25 HC Wainwright & Co.
    Buy
    Mar 26, 25 Citizens Capital Markets
    Market Outperform
    Mar 26, 25 Cantor Fitzgerald
    Overweight
    Jan 31, 25 Cantor Fitzgerald
    Overweight
    Nov 14, 24 HC Wainwright& Co.
    Buy
    Nov 14, 24 HC Wainwright & Co.
    Buy
    Nov 14, 24 BMO Capital
    Outperform

    Institutional Ownership

    Screeners with ACRV included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Acrivon Therapeutics, Inc.?
    • Does Acrivon Therapeutics, Inc. pay dividends?
    • What sector is Acrivon Therapeutics, Inc. in?
    • What industry is Acrivon Therapeutics, Inc. in?
    • What country is Acrivon Therapeutics, Inc. based in?
    • When did Acrivon Therapeutics, Inc. go public?
    • Is Acrivon Therapeutics, Inc. in the S&P 500?
    • Is Acrivon Therapeutics, Inc. in the NASDAQ 100?
    • Is Acrivon Therapeutics, Inc. in the Dow Jones?
    • When was Acrivon Therapeutics, Inc.'s last earnings report?
    • When does Acrivon Therapeutics, Inc. report earnings?

    What is the ticker symbol for Acrivon Therapeutics, Inc.?

    The ticker symbol for Acrivon Therapeutics, Inc. is NASDAQ:ACRV

    Does Acrivon Therapeutics, Inc. pay dividends?

    No, Acrivon Therapeutics, Inc. does not pay dividends

    What sector is Acrivon Therapeutics, Inc. in?

    Acrivon Therapeutics, Inc. is in the Healthcare sector

    What industry is Acrivon Therapeutics, Inc. in?

    Acrivon Therapeutics, Inc. is in the Biotechnology industry

    What country is Acrivon Therapeutics, Inc. based in?

    Acrivon Therapeutics, Inc. is headquartered in United States

    When did Acrivon Therapeutics, Inc. go public?

    Acrivon Therapeutics, Inc.'s initial public offering (IPO) was on November 15, 2022

    Is Acrivon Therapeutics, Inc. in the S&P 500?

    No, Acrivon Therapeutics, Inc. is not included in the S&P 500 index

    Is Acrivon Therapeutics, Inc. in the NASDAQ 100?

    No, Acrivon Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Acrivon Therapeutics, Inc. in the Dow Jones?

    No, Acrivon Therapeutics, Inc. is not included in the Dow Jones index

    When was Acrivon Therapeutics, Inc.'s last earnings report?

    Acrivon Therapeutics, Inc.'s most recent earnings report was on May 14, 2025

    When does Acrivon Therapeutics, Inc. report earnings?

    The next expected earnings date for Acrivon Therapeutics, Inc. is August 13, 2025
    On this page